Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Powdersize specialized in cGMP-compliant contract particle-size reduction and micronization services for pharmaceutical, food, cosmetic, and industrial clients. The company was acquired by Capsugel in 2016; Capsugel was then acquired by Lonza, which significantly expanded the Quakertown site for micronization including highly potent compounds.[1][2][8][4][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Powdersize.